Proteins interacting with cloning scars: A source of false positive protein-protein interactions

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Banks, Charles A S ^a   Boanca, Gina ^a   Lee, Zachary T ^a   Florens, Laurence ^a   Washburn, Michael P ^a,b  

^a STOWERS INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 13; PROTEIN; PTPN13 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TNIP2 PROTEIN, HUMAN;

AFFINITY CHROMATOGRAPHY; BIOSYNTHESIS; CHEMISTRY; GENETICS; HEK293 CELL LINE; HUMAN; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; METABOLISM; MOLECULAR CLONING; OPEN READING FRAME; PROCEDURES; PROTEIN DOMAIN;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CHROMATOGRAPHY, AFFINITY; CLONING, MOLECULAR; HEK293 CELLS; HUMANS; MASS SPECTROMETRY; OPEN READING FRAMES; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 13; PROTEINS; RECOMBINANT FUSION PROTEINS;

EID: 84923360899     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08530     Document Type: Article

References (47)

1. Kim, M. et al. A draft map of the human proteome. Nature 509, 575-81 (2014).
2. Bonetta, L. Interactome under construction. Nature 468, 851-854 (2010).
3. Aebersold, R. & Mann, M. Mass spectrometry-based proteomics. Nature 422, 198-207 (2003).
4. Mellacheruvu, D., Wright, Z. & Couzens, A. The CRAPome: a contaminant repository for affinity purification-mass spectrometry data. Nat. Methods 10, 730-736 (2013).
5. Nguyen, T. & Goodrich, J. Protein-protein interaction assays: eliminating false positive interactions. Nat. Methods 3, 135-139 (2006).
6. Festa, F., Steel, J., Bian, X. & Labaer, J. High-throughput cloning and expression library creation for functional proteomics. Proteomics 13, 1381-99 (2013).
7. Rual, J.-F. et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature 437, 1173-8 (2005).
8. Ewing, R., Chu, P. & Elisma, F. Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol. Syst. Biol. 3, 89 (2007).
9. Nagase, T. et al. Exploration of human ORFeome: high-throughput preparation of ORF clones and efficient characterization of their protein products. DNA Res. 15, 137-49 (2008).
10. Yamakawa, H. High-throughput construction of ORF clones for production of the recombinant proteins. Methods Mol Biol 577, 25-39 (2009).
11. Banks, C. A. S. et al. Controlling for gene expression changes in transcription factor protein networks. Mol. Cell. Proteomics 13, 1510-22 (2014).
12. Van Huffel, S., Delaei, F., Heyninck, K., De Valck, D. & Beyaert, R. Identification of a novel A20-binding inhibitor of nuclear factor-kappa B activation termed ABIN-2. J. Biol. Chem. 276, 30216-23 (2001).
13. Lang, V. et al. ABIN-2 forms a ternary complex with TPL-2 and NF-kappa B1 p105 and is essential for TPL-2 protein stability. Mol. Cell. Biol. 24, 5235-48 (2004).
14. Maekawa, K., Imagawa, N., Nagamatsu, M. & Harada, S. Molecular cloning of a novel protein-tyrosine phosphatase containing a membrane-binding domain and GLGF repeats. FEBS Lett. 337, 200-6 (1994).
15. Nakai, Y., Irie, S. & Sato, T. A. Identification of IkappaBalpha as a substrate of Fasassociated phosphatase-1. Eur. J. Biochem. 267, 7170-5 (2000).
16. Yanagisawa, J. et al. The molecular interaction of Fas and FAP-1. A tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis. J. Biol. Chem. 272, 8539-8545 (1997).
17. Freiss, G. & Chalbos, D. PTPN13/PTPL1: an important regulator of tumor aggressiveness. Anticancer. Agents Med. Chem. 11, 78-88 (2011).
18. Ciccarelli, F., Bork, P. & Kerkhoff, E. The KIND module: a putative signalling domain evolved from the C lobe of the protein kinase fold. Trends Biochem. Sci. 28, 349-352 (2003).
19. Frame, M. C., Patel, H., Serrels, B., Lietha, D. & Eck, M. J. The FERM domain: organizing the structure and function of FAK. Nat. Rev. Mol. Cell Biol. 11, 802-14 (2010).
20. Nourry, C., Grant, S. G. N. & Borg, J.-P. PDZ domain proteins: plug and play! Sci. STKE 2003, re7 (2003).
21. Fanning, A. S. & Anderson, J. M. Protein-protein interactions: PDZ domain networks. Curr. Biol. 6, 1385-8 (1996).
22. Songyang, Z. Recognition of unique carboxyl-terminal motifs by distinct PDZ domains. Science 275, 73-77 (1997).
23. Doyle, D. a. et al. Crystal structures of a complexed and peptide-free membrane protein-binding domain: molecular basis of peptide recognition by PDZ. Cell 85, 1067-76 (1996).
24. Gavin, A.-C., Maeda, K. & Kühner, S. Recent advances in charting protein-protein interaction: mass spectrometry-based approaches. Curr. Opin. Biotechnol. 22, 42-9 (2011).
25. Bensimon, A., Heck, A. J. R. & Aebersold, R. Mass Spectrometry-Based Proteomics and Network Biology. Annu. Rev. Biochem. 81, 1-27 (2012).
26. Nagase, T., Yamakawa, H. & Ohara, O. Value-Added Human Flexi® ORF Clones with HaloTag® Labeling Technology. (2009). at http://www.promega.com/resources/pubhub/value-added-human-flexi-orf-clones-with-halotag-labelingtechnology/..
27. Wissmueller, S. et al. Protein-protein interactions: analysis of a false positive GST pulldown result. Proteins 79, 2365-71 (2011).
28. Ho, Y. et al. Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature 415, 180-3 (2002).
29. Sowa, M. E., Bennett, E. J., Gygi, S. P. & Harper, J. W. Defining the human deubiquitinating enzyme interaction landscape. Cell 138, 389-403 (2009).
30. Gibson, T. J., Seiler, M. & Veitia, R. A. The transience of transient overexpression. Nat. Methods 10, 715-721 (2013).
31. Tonikian, R. et al. A specificity map for the PDZ domain family. PLoS Biol. 6, e239 (2008).
32. Ioannidis, J. P. A. Why most published research findings are false. PLoS Med. 2, e124 (2005).
33. Prinz, F., Schlange, T. & Asadullah, K. Believe it or not: how much can we rely on published data on potential drug targets? Nat. Rev. Drug Discov. 10, 712 (2011).
34. Macarthur, D. Face up to false positives. Nature 487, 427-428 (2012).
35. Russell, J. F. If a job is worth doing, it is worth doing twice. Nature 496, 7 (2013).
36. Fields, S. High-throughput two-hybrid analysis. The promise and the peril. FEBS J. 272, 5391-9 (2005).
37. Mackay, J. P., Sunde, M., Lowry, J. A., Crossley, M. & Matthews, J. M. Protein interactions: is seeing believing? Trends Biochem. Sci. 32, 530-1 (2007).
38. Matt, T., Martinez-Yamout, M., Dyson, H. & Wright, P. The CBP/p300 TAZ1 domain in its native state is not a binding partner of MDM2. Biochem. J 381, 685-91 (2004).
39. Lee, B., Buck-Koehntop, B., Martinez-Yamout, M., Dyson, H. & Wright, P. Embryonic neural inducing factor churchill is not a DNA-binding zinc finger protein: solution structure reveals a solvent-exposed beta-sheet and zinc binuclear cluster. J. Mol. Biol. 371, 1274-1289 (2007).
40. Blommel, P. G., Martin, P. A., Seder, K. D., Wrobel, R. L. & Fox, B. G. Flexi Vector Cloning. Methods Mol. Biol. 498, 55-73 (2009).
41. Florens, L. & Washburn, M. P. Proteomic analysis by multidimensional protein identification technology. Methods Mol. Biol. 328, 159-75 (2006).
42. Eng, J. K., McCormack, A. L. & Yates, J. R. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 5, 976-989 (1994).
43. Tabb, D. L., McDonald, W. H. & Yates, J. R. DTASelect and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics. J. Proteome Res. 1, 21-6 (2002).
44. Zhang, Y., Wen, Z., Washburn, M. P. & Florens, L. Refinements to label free proteome quantitation: how to deal with peptides shared by multiple proteins. Anal. Chem. 82, 2272-81 (2010).
45. Pavelka, N. et al. Statistical similarities between transcriptomics and quantitative shotgun proteomics data. Mol. Cell. Proteomics 7, 631-44 (2008).
46. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57, 289-300 (1995).
47. Desiere, F. et al. The Peptide Atlas project. Nucleic Acids Res. 34, D655-8 (2006).